VF
CLYM

Virtu Financial’s Climb Bio CLYM Stock Holding History

Virtu Financial’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
+11,151
New +$115K ﹤0.01% 1031
2026
Q1 		– Sell
-10,655
Closed -$43K – 2451
2025
Q4 		$43K Buy
+10,655
New +$25.6K ﹤0.01% 1326
2025
Q1 		– Sell
-11,733
Closed -$21K – 2184
2024
Q4 		$21K Buy
+11,733
New +$42.5K ﹤0.01% 1294

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Virtu Financial's CLYM Position: Q2 2026 in Review

Virtu Financial opened a new position in Climb Bio (CLYM) in Q2 2026: 11,151 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #1031 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CLYM as recently as Q4 2025.

Virtu Financial first reported a position in CLYM in Q4 2024 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Virtu Financial held 11,151 shares of Climb Bio worth $145K as of Q2 2026.
  • Climb Bio was a new Virtu Financial position in Q2 2026.
  • Climb Bio made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1031 holding.
  • Virtu Financial first reported a position in Climb Bio in Q4 2024 and has held it in 3 quarters since.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.